NGT1, NGT2: Europe Redefines the Line Between Plant Breeding and Genetic Engineering

NGT1, NGT2: Europe Redefines the Line Between Plant Breeding and Genetic Engineering

by Laurent Glatz – for Athletic Carnivore

A plant can be modified without receiving foreign DNA. It can carry a targeted mutation, a small deletion, a substitution, or a precise correction, yet change its resistance, composition, stress tolerance, or agronomic value. This exact point makes new genomic techniques so explosive: they blur the boundary between classical breeding and genetic engineering.

NGTs, or new genomic techniques, include genome editing methods like CRISPR, targeted mutagenesis, or certain forms of cisgenesis. The difference with traditional GMOs is crucial. In popular imagination, GMOs often mean adding a gene from a foreign species. With NGTs, the intervention can be much more subtle: modifying a phrase in the genetic text rather than pasting a paragraph from another biological book.

This subtlety creates legal challenges. If a modification could theoretically arise through natural mutation or conventional breeding, should it be treated like a classic GMO? Or should it be considered an accelerated version of plant breeding? The European Union has chosen to respond with two categories: NGT1 and NGT2.

NGT1 plants are those whose modifications are considered equivalent to what nature or conventional breeding could produce. They must undergo a status verification but would not be subject to the heavy regulatory regime of traditional GMOs. NGT2 plants, more complex or further from this equivalence, remain under a stricter logic: authorization, traceability, risk assessment, and labeling.

Thus, the debate is not only technical. It revolves around the regulatory definition of equivalence. A plant can be technologically edited yet legally aligned with conventional breeding. This is the tipping point. Naturalness ceases to be an intuitive notion and becomes an administrative category.

This evolution can have real advantages. In an unstable climate, plants more resistant to drought, certain diseases, or agronomic stresses can reduce losses, secure supply chains, accelerate breeding, and decrease some inputs. For farmers, the stakes are concrete: yield, stability, adaptation, seed sovereignty.

But the food question cannot stop there. A plant that performs better agronomically is not necessarily more nutritious. It may be designed to resist, produce, travel, store, or meet industrial specifications. The metabolic quality of the food is not automatically the focus of innovation. An edited cereal remains a cereal in its glycemic response. A more profitable plant is not necessarily one that better nourishes the human body.

The issue of patents is equally decisive. While genome editing accelerates variety creation, it can also concentrate power around technology holders, platforms, intellectual property rights, and seed catalogs. The NGT debate is therefore not only scientific. It is agricultural, economic, and political: who controls the seeds, who pays for access to innovation, who decides what will be grown tomorrow?

Organic farming remains a major point of tension. NGTs are excluded from organic production under the current framework. This exclusion creates a multi-speed agriculture: classic conventional, NGT1-edited conventional, more regulated NGT2, and organic separately. Consumers will need to understand not only what they eat but how the plant was developed, which category it falls into, and what that category truly means.

As of May 29, 2026, the dossier is at an advanced stage: the Council of the European Union adopted its position on April 21, 2026, following a prior political agreement and parliamentary work. But full operational implementation depends on the conclusion of the procedure, publication, and adaptation period. The shift is underway but not yet fully established in every field and store shelf.

The real question is not to demonize all genome editing nor to applaud it naively. The real question is more demanding: what are we trying to optimize? Agricultural resilience? Yield? Dependence on seed companies? Logistics? Nutritional quality? Food sovereignty?

Because once we accept precisely modifying life, we must also precisely examine the objectives. Modifying a plant is not neutral. Even when no foreign DNA is added, we select a direction for agriculture and thus for future food.

And if the true debate is not whether NGTs are “natural” or not, but who will have the power to define tomorrow what the word natural still has the right to mean?

#NGT #NGT1 #NGT2 #CRISPR #Seeds #Agriculture #Biotechnologies #EuropeanUnion #GeneticEngineering #AthleticCarnivore